Needle exchange program participation by anabolic steroid injectors, United States 1998

Drug and Alcohol Dependence

Volumn 56, Issue 2, 1999, Pages 157-160

  Rich, Josiah D ^a   Foisie, Craig K ^a   Towe, Christopher W ^a   Dickinson, Brian P ^a   McKenzie, Michelle ^a   Salas, Christopher M ^a  

^a MIRIAM HOSPITAL   (United States)

Author keywords

Anabolic steroids; HIV; Intravenous; Needle exchange programs; Needle sharing; Substance abuse

Indexed keywords

ANABOLIC AGENT;

ARTICLE; CLINICAL TRIAL; DISEASE TRANSMISSION; DRUG ABUSE; EDUCATION; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEEDLE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; UNITED STATES;

ANABOLIC AGENTS; HUMANS; NEEDLE-EXCHANGE PROGRAMS; QUESTIONNAIRES; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 0032793567     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(99)00035-6     Document Type: Article

References (29)

1. Crampin A.C., Lamagni T.L., Hope V.D., Newham J.A., Lewis K.M., Parry J.V., Gill O.N. The risk of infection with HIV and hepatitis B in individuals who inject steroids in England and Wales. Epidemiol. Infect. 121(2):1998;381-386.
2. Dezelsky T.L., Toohey J.V., Shaw R.S. Non-medical drug use behavior at five United States universities: a 15-year study. Bull. Narc. 37:1985;49-53.
3. Dukarm C.P., Byrd R.S., Auinger P., Weitzman M. Illicit substance use, gender, and the risk of violent behavior among adolescents. Arch. Pediatr. Adolesc. 150(8):1996;797-801.
4. Evans N.A. Local complications of self administered anabolic steroid injections. Br. J. Sports. Med. 31(4):1997;349-350.
5. Faigenbaum A.D., Zaichkowsky L.D., Gardner D.E., Micheli L.J. Anabolic steroid use by male and female middle school students. Pediatrics. 101(5):1998;E6.
6. Gostin L.O. The legal environment impeding access to sterile syringes and needles: the conflict between law enforcement and public health. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 18 Suppl. 1:1998;S60-S70.
7. Hausmann R., Hammer S., Betz P. Performance enhancing drugs (doping agents) and sudden death - a case report and review of the literature. Int. J. Legal Med. 111(5):1998;261-264.
8. Heimer R., Khoshnood K., Bigg D., Guydish J., Junge B. Syringe use and reuse: effects of syringe exchange programs in four cities. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 18(1):1998;S37-S44.
9. Hurley S.F., Jolley D.J., Kaldor J.M. Effectiveness of needle exchange programmes for prevention of HIV infection. Lancet. 349(9068):1997;1797-1800.
10. Kashkin K.B., Kleber H.D. Hooked on hormones? An anabolic steroid addiction hypothesis. JAMA. 262(22):1989;3166-3170.
11. Korkia P., Stimson G.V. Indications of prevalence, practice and effects of anabolic steroid use in Great Britain. Int. J. Sports Med. 18(7):1997;557-562.
12. Kuipers H., Wijnen A.G., Hartgens F., Willelms S.M. Influence of anabolic steroids on body composition, blood pressure, lipid profile and liver functions in body builders. Int. J. Sports Med. 12:1991;413-418.
13. Lloyd F.H., Powell P., Murdoch A.P. Anabolic steroid abuse by body builders and male subfertility. BMJ. 313(7049):1996;100-101.
14. North American Syringe Exchange Network, 1997. NASEC VII Seventh North American Syringe Exchange Convention Participants' List. San Diego.
15. Paone D., Des Jarlais D.C., Singh M.P., Grove D., Shi Q. Update: Syringe Exchange Programs - United States, 1997. MMWR. 47(31):1998;652-655.
16. Paone D., Clark J., Shi Q., Purchase D., Des Jarlais D. Syringe exchange in the United States, 1996: a national profile. Am. J. Public Health. 89(1):1999;43-46.
17. Perry H.M., Wright D., Littlepage B.N. Dying to be big: a review of anabolic steroid use. Br. J. Sports Med. 26(4):1992;259-261.
18. Rich J.D., Dickinson B.P., Carney J.M., Fisher A., Heimer R. Detection of HIV-1 nucleic acid and HIV-1 antibodies in needles and syringes used for non-intravenous injection. AIDS. 12:1998;2345-2350.
19. Rich J.D., Dickinson B.P., Merriman N.A., Flanigan T.P. Hepatitis C virus infection related to anabolic-androgenic steroid injection in a recreational weight lifter. Am. J. Gastroenterol. 93(9):1998;1598.
20. Rich J.D., Dickinson B.P., Merriman N.A., Thule P.M. Insulin use by bodybuilders. JAMA. 279(20):1998;1613.
21. Rich, J.D., Dickinson, B.P., Flanigan, T.P., Valone, S.E., 1999. Abscess related to anabolic-androgenic steroid injection: case report and review of the literature, Med. and Sci. Sports Exer. 31 (2), 207-209.
22. Rockhold R.W. Cardiovascular toxicity of anabolic steroids. Annu. Rev. Pharmacol. Toxicol. 33:1993;497-520.
23. Scott D.M., Wagner J.C., Barlow T.W. Anabolic steroid use among adolescents in Nebraska schools. Am. J. Health Syst. Pharm. 53(17):1996;2068-2072.
24. Scott, M.J., Scott, M.J. Jr, 1989. HIV infection associated with injections of anabolic steroids. JAMA 262(2), 208.
25. Singh S., Kumar J., Singh R. Spread of HIV and hepatitis viruses through the use of injection needles for Kala-azar therapy in India. 12th World AIDS Conference Geneva. June. 28-July:1998;3.
26. Sklarek H.M., Mantovani R.P., Erens E., Heisler D., Neiderman M.S., Fein A.M. AIDS in a bodybuilder using anabolic steroids. N. Engl. J. Med. 311(26):1984;1701.
27. Terney R., McLain L.G. The use of anabolic steroids in high school students. AJDC. 144:1990;99-103.
28. Tricker R., O'Neill M.R., Cook D. The incidence of anabolic steroid use among competitive bodybuilders. J. Drug Educ. 19:1989;313-325.
29. Yesalis C.E., Kennedy N.J., Kopstein A.N., Bahrke M.S. Anabolic-androgenic steroid use in the United States. JAMA. 270(10):1993;1217-1221.